India Pharma Outlook Team | Tuesday, 22 July 2025
In a significant advancement in areas of adult and geriatric care, Akums Drugs & Pharmaceuticals Ltd. has released India's first high-strength paracetamol oral suspension at 500mg/5ml, establishing a new model for the country's pharmaceutical space.
This formulation has twice the strength of conventional syrups being offered at 250mg/5ml, providing a full adult dose in just 5ml. This formulation not only is easy to administer, but it allows for confident dosing even in these common types of care situations where patient's (especially elders) had difficulty with swallowing tablets or measuring out larger quantity doses.
Akums' latest product is timely due to the increases in home-based healthcare and self-medication trends. The company's innovation has addressed the lack of solutions for patient-friendly, easy to administer types of products. Akums also mentioned the convenience and compliance these suspensions may promise while minimizing any potential confusion with displaying "5ml = 500mg" on the dosing containers.
Also Read: How Advanced Training Methods can Enhance Patient Care
The formulation is positioned to support India's new community based healthcare model, and give more options to doctors and caregivers for pain and fever management. It should help to reduce volume taken per dose, establish medication familiarity and increase patient compliance in comparison to missed doses or traditional forms, while also supporting comprehensive global best practices for adult medicine.
Akums, known for its extensive CDMO expertise and a portfolio of over 4,000 formulations, continues to lead with innovation. This launch reaffirms its commitment to developing therapeutically effective, user-centric formulations that elevate treatment outcomes and improve quality of care.
With this advancement, Akums sets a new benchmark in oral analgesic therapy, reinforcing its leadership in India’s pharmaceutical industry.
